Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (MT), an acid-fast, gram-positive bacillus that poses a major global health threat. Despite the availability of first-line and second-line anti-TB drugs, TB remains one of the top causes of mortality from infectious diseases, particularly in low- and middle-income countries. The emergence of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) strains has significantly reduced the efficacy of existing treatment regimens, highlighting the urgent need to discover and develop novel therapeutic agents with enhanced efficacy and safety profiles. Schiff bases, known for their diverse biological activities, including antibacterial, antifungal, and anticancer properties, have recently gained attention as promising pharmacophores in drug development. In this study, we evaluated a series of vanillin-derived Schiff base compounds (S1–S6) for their potential anti-tubercular activity through molecular docking studies. The selected compounds were screened against two critical enzymes essential for the survival and proliferation of Mycobacterium tuberculosis: DprE1 (decaprenyl phosphoryl-β-D-ribose 2′-epimerase), involved in cell wall biosynthesis, and DNA gyrase subunit A, crucial for DNA replication. Molecular docking was performed to assess the binding affinity, binding modes, and interaction profiles of these ligands with the target proteins. The results demonstrated that all compounds (S1–S6) exhibited strong and favorable binding interactions with the active sites of both enzymes. Notably, their docking scores and interaction energies were superior to those of currently used anti-TB drugs such as isoniazid, bedaquiline, pyrazinamide, and the standard reference ethambutol (S7). These findings suggest that the vanillin-based Schiff bases have significant inhibitory potential against Mycobacterium tuberculosis and could serve as promising lead compounds for future in vitro and in vivo studies aimed at developing new anti-TB therapies
23 June 2025 in Journal of Microbiological Sciences
Nanotechnology is notorious and dynamic procedure focusing nanoparticles sizes from one nanometer to hundred nanometer in the recent and novel logical and and scientific research of nanotechnology. Nanoparticles are largely employed because of their negligible size. Several techniques like chemical technique physical process and biogenic process can be assumed for the nanoparticle’s synthesis. Among the biogenic method, chemical method and physical methods, biogenic method is good, harmless and new method for the synthesis of different metallic nanoparticles because biological method is comfortable, easy and ecofriendly process as compare to the chemical and physical method. This study practice equisetum ramosissimum, which is healing and remedial plant created in valley of Swat, in Pakistan to synthesize silver (Ag-NPs) nanoparticles. Plant extracts of equisetum ramossissimum and silver nitrate (AgNO3) salt was prepared, and these two solutions were blended for the synthesis method. Abundant approaches, such as UV-Vis spectrophotometry, Fourier Transmission Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), X-Ray diffraction (XRD) analysis, Scanning and Atomic Force Microscopy (AFM), were employed for analysis the resultant Silver nanoparticles (Ag-NPs). These results exhibited that nanoparticles were synthesized in nano dimension range. Furthermore, silver nanoparticles have shown good antimicrobial activities against bacteria like pseudomonas aeruginosa and Erwinia caratovora, Salmonella Typhi, Serratia marcescens, Morganelli morganii and pseudomonas syringae